Fathom Therapeutics secured $47M in Series A funding to advance its drug design using AI and physics-based simulations. Zamp raised $30M for its AI-driven sales tax compliance platform. Liquid obtained $18M in Seed funding for its multi-asset trading platform. Windmill raised $12M for its workforce intelligence platform. These funding rounds reflect the growing interest and investment in innovative technology startups in New York City.
"Fathom Therapeutics, a drug design company that uses physics-based simulations and AI to design novel small molecules by modeling protein motion at atomic resolution, has raised $47M in Series A funding led by Sutter Hill Ventures, with participation from Chemistry, Alexandria Venture Investments, and Empire State Development's NY Ventures."
"Zamp, a sales tax compliance platform that combines AI agents with in-house tax and legal professionals to manage the full sales tax lifecycle for e-commerce, SaaS, and accounting firms, has raised $30M in funding led by Acrew Capital, with participation from Thomson Reuters Ventures."
"Liquid, a multi-asset trading platform that consolidates access to crypto, equities, commodities, FX, and pre-IPO markets into a single 24/7 interface, has raised $18M in Seed funding co-led by Neo and Left Lane Capital, with participation from Haun Ventures, K5 Global, SV Angel, AntiFund, Sunflower Capital, Paradigm, and General Catalyst."
"Windmill, a workforce intelligence platform that builds and continuously updates an AI-powered understanding of workforce dynamics, has raised $12M in funding to enhance its capabilities."
Read at AlleyWatch
Unable to calculate read time
Collection
[
|
...
]